Dana Investment Advisors’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-6,513
Closed -$249K 433
2023
Q3
$249K Sell
6,513
-9,640
-60% -$395K 0.01% 380
2023
Q2
$583K Sell
16,153
-128,915
-89% -$4.4M 0.03% 295
2023
Q1
$5.54M Buy
145,068
+55,036
+61% +$2.58M 0.28% 85
2022
Q4
$5.12M Buy
+90,032
New +$4.61M 0.27% 89

Other funds holding HALO

Dana Investment Advisors's HALO Position: Q4 2023 in Review

Dana Investment Advisors sold out of Halozyme (HALO) in Q4 2023, closing a stake of 6,513 shares — an estimated $249K sold.

Dana Investment Advisors first reported a position in HALO in Q4 2022 and held it in 4 quarters. The position peaked at $5.54M in Q1 2023. 410 funds tracked by Wall St. Rank hold HALO as of Q4 2023.

  • Dana Investment Advisors reported no remaining Halozyme position as of Q4 2023 after selling out during the quarter.
  • Dana Investment Advisors sold 6,513 Halozyme shares in Q4 2023, an estimated $249K.
  • Dana Investment Advisors first reported a position in Halozyme in Q4 2022 and held it in 4 quarters.
  • Dana Investment Advisors's Halozyme position peaked at $5.54M in Q1 2023.
  • 410 funds tracked by Wall St. Rank held Halozyme as of Q4 2023.

Based on Dana Investment Advisors's 13F filing for Q4 2023, filed 7 Feb 2024.